Eli Lilly to acquire three small vaccine developers
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
Eli Lilly weight loss drug data supports long-term obesity market position, says UBS
Eli Lilly weight loss drug data supports long-term obesity market position, says UBS Proactive uses images sourced from…
Healthcare Stocks Are on Fire — Don’t Miss These Opportunities
The healthcare sector just had its best week in six months. The State Street Health Care Select Sector…
From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
Key Points Interested in Eli Lilly and Company? Here are five stocks we like better. Eli Lilly saw…
Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say
By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
Weight lost with GLP-1 drugs still subject to rebound after stopping treatment – Baltimore Sun
Weight lost with GLP-1 drugs still subject to rebound after stopping treatment Baltimore SunA pill helps you keep weight…
Could Eli Lilly’s Next Weight Loss Drug Waylay Wegovy — and Even Zap Zepbound?
After losing its market edge to Eli Lilly (NYSE: LLY) despite its first-mover advantage in weight-loss drugs, Novo…
Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders
Novo Nordisk has shared new data that suggests a higher dose version of its blockbuster weight loss drug,…
Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss
Eli Lilly and Co. (NYSE:LLY) on Wednesday released detailed findings from two late-stage obesity studies showing patients were…
Medicare spending far less than expected on new Alzheimer’s drugs
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Scoring 2 Million Prescriptions, Novo’s GLP-1 Pill Crushes Expectations
Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built…
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.
Last year, Eli Lilly (NYSE: LLY) made history when it became the first healthcare company to reach a…